Work

OA13.03 RYZ101 (225Ac-DOTATATE) + Carboplatin + Etoposide + Atezolizumab in Somatostatin Receptor-Expressing Extensive-Stage SCLC

Year: 2025

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.075

Authors: A.S. Mansfield, E. Parent, N. Rivera-Rodriguez, Z. Hao, D. Bushnell, C. Mulvey, S. Mehr, J. Goldman, J. Calais, M. Thakur, B. Mancini, J.M. Rineer, Y. Yuan, J. Li, L. Gong, D. Ferreira, A. Mettias, H. Soares

Institutions: Mayo Clinic, Mayo Clinic in Florida, Markey Cancer Center, University of Iowa, University of California, San Francisco, Nebraska Cancer Specialists, University of California, Los Angeles, Corewell Health, Orlando Health, Huntsman Cancer Institute

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519196

Cites:

Cited by: 1

Related to: 10